HOMA-IR (Homeostatic Model Assessment for Insulin Resistance)
ورودیهای بالینی بیمار
حداقل ۰.۱ — حداکثر ۳۰۰ • واحد: μIU/mL
حداقل ۱۰ — حداکثر ۶۰۰ • واحد: mg/dL
پارامترهای بالینی بیمار را در فرم روبرو وارد کنید و روی «محاسبه» کلیک نمایید تا نمره، طبقه خطر و اقدامات فوری نمایش داده شوند.
- Low0–0.7
- Normal0.7–2
- Borderline2–2.5
- Moderate2.5–5
The HOMA-IR (Homeostatic Model Assessment for Insulin Resistance) calculates evaluating glycemic control, metabolic decompensation severity, and long-term endocrine risks. Key inputs include fasting insulin. Scores guide titrating insulin infusion protocols, managing fluid-electrolyte resuscitation, and long-term risk reduction. This standardized assessment improves clinical decision safety and bedside patient management.
Clinical Guidelines & Evidence
Approximates insulin resistance using fasting glucose and insulin levels. A simple, non-invasive method to quantify insulin resistance and beta-cell function.
Clinical Indication
The HOMA-IR (Homeostatic Model Assessment for Insulin Resistance) is indicated for bedside clinical practice to support Approximates insulin resistance using fasting glucose and insulin levels. A simple, non-invasive method to quantify insulin resistance and beta-cell function.. It assists healthcare providers in standardizing clinical assessment and therapeutic decision-making.
Target Population
Target population comprises Patients presenting with diabetes mellitus, diabetic ketoacidosis (DKA), hyperosmolar hyperglycemic state, thyroid storm, or adrenal crisis. Clinical application is indicated across Endocrinology clinics, inpatient metabolic services, and acute diabetes care units.
Limitations & Contraindications
Severe hyperglycemia lowers measured serum sodium; corrected sodium equations must guide intravenous fluid selection.
Clinical Pearls & Action Plan
Serial monitoring of serum electrolytes, potassium kinetics, venous pH, and anion gap is mandatory during acute metabolic crisis management.
HOMA-IR = (Fasting Insulin [μIU/mL] × Fasting Glucose [mg/dL]) / 405
Input Parameters
| Name | Type | Required | Description |
|---|---|---|---|
| fasting_insulin | float | Yes | Fasting insulin level (must be fasting for at least 8 hours)(μIU/mL) |
| fasting_glucose | float | Yes | Fasting glucose level (must be fasting for at least 8 hours)(mg/dL) |
Score Interpretation & Guidance
| Range | Stage | Description |
|---|---|---|
| 0–0.7 | Low | Below normal range |
| 0.7–2 | Normal | Normal insulin sensitivity |
| 2–2.5 | Borderline | Borderline insulin resistance |
| 2.5–5 | Moderate | Moderate insulin resistance |
| 5–999999 | Severe | Severe insulin resistance |
Evidence-Based References (EBM)
- Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985 Jul;28(7):412-9.
- Tohidi M, Ghasemi A, Hadaegh F, Derakhshan A, Chary A, Azizi F. Age- and sex-specific reference values for fasting serum insulin levels and insulin resistance/sensitivity indices in healthy Iranian adults: Tehran Lipid and Glucose Study. Clin Biochem. 2014 Apr;47(6):432-8.